Alivus Life Sciences announces 14th AGM on September 8, 2025; sets record date
The announcement is routine and relates to standard corporate governance matters.
The announcement primarily conveys factual information regarding the AGM and dividend.
* Alivus Life Sciences Limited will hold its 14th Annual General Meeting (AGM) on Monday, September 8, 2025, at 03:00 pm (IST) via Video Conferencing. * The Board of Directors has recommended a final dividend of ₹ 5.00 per equity share of ₹ 2 each for the financial year ended March 31, 2025, subject to shareholder approval at the AGM. * The record date for determining entitlement to the dividend is set as Monday, September 1, 2025. * If approved, dividend payments will be made on or after Friday, September 12, 2025.
What to do with a filing like this
Alivus Life Sciences Limited filed this with the NSE as a statutory disclosure, categorised under agm-egm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Alivus Life Sciences Limited. Read the original for the full detail.